生物活性 | |||
---|---|---|---|
描述 | Thymalfasin (thymosin-alpha 1) is an immunomodulating agent able to enhance the Thl immune response. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT00935558 | Breast Cancer | Phase 2 | Withdrawn(no patients enrolled... 展开 >>) 收起 << | - | Denmark ... 展开 >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 收起 << |
NCT03659578 | Non-small Cell Lung Cancer | Phase 2 | Recruiting | September 2020 | China, Guangdong ... 展开 >> Sun yat-sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510000 Contact: Bo Qiu, Attending +86-020-87343031 qiubo@sysucc.org.cn Contact: Hui Liu, Professor 收起 << |
NCT00040027 | Hepatitis C H... 展开 >>epatitis C, Chronic 收起 << | Phase 3 | Completed | - | - |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
0.32mL 0.06mL 0.03mL |
1.61mL 0.32mL 0.16mL |
3.22mL 0.64mL 0.32mL |
参考文献 |
---|